1. Abbott Laboratories. August 1996. Norvir™ (technical information). Abbott Laboratories North Chicago Ill.
2. Ergotism as a consequence of thromboembolic prophylaxis;Ashenburg R. J.;Radiology,1989
3. Severe iatrogenic ergotism: incidence and clinical importance;Bongard O.;VASA,1991
4. Kempf D. K. Marsh J. Denissen et al. 1996. Coadministration with ritonavir enhances the plasma levels of HIV protease inhibitors by inhibition of cytochrome P450. In Program and abstracts of the Third Conference on Retroviruses and Opportunistic Infections.
5. Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes;Kumar G. N.;J. Pharmacol. Exp. Ther.,1996